Following a turbulent year for the markets in general and biotech in particular, the industry made a notable recovery, ...

Pharmaceutical stocks are making a comeback as valuations remain attractive and companies successfully address patent cliff ...

In this article, we will discuss the 9 Best Biotech Penny Stocks to Buy in 2026. On April 24, Drew Pettit, Citi US equity ...

This shift is particularly meaningful for companies operating outside traditional pharmaceutical pipelines and, as AI reduces bottlenecks in trials, the next constraint becomes commercialization: how ...

Expect the push higher for tech stocks to keep going, says Barclays as Wall Street gets on board. They flag their favorite ...

What's next for the beaten-down ASX biotech stock? The post CSL shares crash to a 9-year low. Is it time to sell off my ...

The NASDAQ has a reputation for providing a platform for some of the world's most innovative companies. The post This ASX biotech is pushing for a Nasdaq listing. Could it reignite investor interest?

If you bought XBI a year ago and held it, you are up roughly 65%. If you bought Direxion Daily S&P Biotech Bull 3X Shares ...

We just covered the Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential and Protagonist Therapeutics, Inc.

We just covered the Billionaire Joe Edelman’s 10 Stock Picks with Huge Upside Potential and Ascendis Pharma A/S (NASDAQ:ASND) ...

Tech stocks gained nearly 3% this past week, leading the overall market further into record territory. Check out my ...

Biotech has reasserted itself over the past year as drug approvals, obesity and GLP-1 programs, oncology pipelines, and ...